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ABSTRACT:
Pulmonary Sarcomatoid Carcinoma is a rare, aggressive tumor comprising of both epithelial and mesenchymal cells.
It is important to distinguish it from other lung tumors due to its poor prognosis and extensive metastasis. We present
a case of a 36 year old female patient who initially presented with right sided weakness and slurred speech due to an
ischemic infarct of the left basal ganglia. Further workup revealed a lung mass extending to the left atrium with spinal
metastasis. Sarcomatoid Carcinoma remains a diagnostic challenge due to its early recurrence and atypical
presentation.
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INTRODUCTION: Sarcomatoid Carcinoma (SC) is a
rare malignant tumor characterized by both
sarcomatous and carcinomatous features. Despite an
epithelial origin, the tumor contains a combination of
both epithelial and mesenchymal components1. Found
in various organs, this malignancy comprises about 1%
of all lung neoplasms It can appear centrally or
peripherally in the lungs but is more commonly found
as a peripheral solitary mass with an affinity for the
upper lobes2,3. Smoking, alcohol use, previous history
of radiation therapy and asbestos exposure are some of
the established risk factors of this condition 4,5. The
disease is four times more commonly found in men
than women. The average age of diagnosis ranges
between 65 to 75 years6. Though it has a variable
clinical presentation, some typical symptoms of
pulmonary SC include chest pain, cough, dyspnea and
fever7. It is important to distinguish this tumor from
other mesenchymal neoplasms due to its aggressive
nature, poor prognosis and extensive metastasis.
Majority of cases are diagnosed at a later stage when
there is multiple metastasis.We present a rare case of
a patient with Pulmonary Sarcomatoid Carcinoma with
left atrial involvement and spinal metastasis who
presented with an ischemic infarct of the left basal
ganglia. Pulmonary Sarcomatoid Carcinomas represent
0.2-1% of all lung cancers. We report the first case of
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female
patient
non-smoker
with
pulmonary
sarcomatoid carcinoma with left atrial involvement and
spinal metastasis who presented with ischemic infarct
from Pakistan.
Case report:
36-year-old Asian lady without any prior known
comorbids presented to the emergency department
with right sided body weakness and numbness with
associated slurred speech for one day.During the last 1
week she had shown recurrent episodes of
paresthesias and numbness in right upper and lower
extremity. In between these episodes, patient was back
to normal without any residual symptoms. On
examination, she had a blood pressure of 110/70 mm
Hg, a heart rate of 80bpm, a temperature of 370C, and
a respiratory rate of 18 breaths per minute. On
neurological exam she was awake alert and oriented.
She had weakness in right arm with power of 4/5, chest
and cardiac examination was normal . ECG showed
normal sinus rhythm. Baseline laboratory investigations
were within normal limits. 3 months prior to admission
she had dry cough, progressive exertional dyspnea and
palpitations for which workup was done her chest X-ray
done in January 2019 showing right upper lobe
consolidation, followed by CT chest in February 2019,
which revealed irregular, partially enchaining hyper

26

VOL. 15 (2)

APRIL-JUNE 2020

dense heterogenous soft tissue mass in right hilar
region (6x2 cm) causing pressure effect to adjacent
structures encasing right bronchus. Multiple small
round nodules were noted in both lungs. On
echocardiogram multiple echogenic masses in left
atrium were noted with largest echogenic mass (4x6
cm) in occupying 80% space with extension to the
mitral valve leaflet anteriorly causing obstructive flow.
She had
no history of tobacco, alcohol or use of
recreational drugs no history of weight loss. Strong
family history of malignancy in grandparents (breast
and uterine) and uncle (prostate carcinoma) was
present. She had past history of leiyomyoma and
myomectomy was done in 2016. Based on history and
relevant investigations, an initial impression of a
possible left sub-cortical infarct, with possibility of
involvement of lung mass was made and brain imaging
with contrast was ordered with workup for malignancy.
Magnetic resonance imaging (MRI) of the brain with
gadolinium contrast revealed. Acute left basal ganglia
infarct.Middle cerebral arteries to be patent and normal
in calibre.Magnetic resonance angiography(MRA) and
magnetic resonance venography (MRV) were normal.

Figure 2 showing Abnormal signal with
enhancement involving C4 vertebral body with
associated left paravertebral soft tissue lesion
extending from C3 to C5 vertebral levels.

Figure 3 A large heterogenously enhancing soft
tissue mass lesion in right upper hemithorax
arising from right lung
Discussion
The World Health Organization has defined Pulmonary
Sarcomatoid Carcinomas as ‘poorly differentiated
non-small cell lung carcinomas (NSCLCs) containing a
sarcoma-like element (malignant spindle or giant cells)
or sarcomatous component’. Based on this definition,
these tumors have been further classified into 5 types
called pleomorphic carcinoma, giant cell carcinoma,
carcinosarcoma, spindle cell carcinoma and pulmonary
blastoma8. These tumors are diagnosed based on their
characteristic morphological appearance on light
microscopy. Immunohistochemistry acts as an
adjunctive diagnostic tool to help rule out other
morphologically similar lesions.

Figure 1 A and B showed Left basal ganglion
infarct with diffusion restriction and ADC drop out.
Cervical MRI with contrast was done which showed left
paravertebral soft tissue lesion extending from C3 to C5
vertebral levels, these lesions were suggestive of
metastatic origin.
C.T chest with contrast was repeated later also which
was suggestive of large heterogeneous right upper lobe
neoplastic mass lesion, measuring approximately 99 x
83 x 139 mm in AP, transverse and craniocaudal
dimensions associated with thrombus in pulmonary
vein extending up to the left atrium, likely representing
tumor thrombus in left atrium and multiple bilateral
pulmonary metastatic deposits .

A, confirming the diagnosis of pleomorphic carcinoma.
Studies have shown that using cytokeratin AE1/AE3 is
usually enough to support the diagnosis of pulmonary
SC9. TTF-1 and Napsin have also been implicated in the
diagnosis of SC.

C.T guided biopsy of right upper lobe mass showed
sarcomatoid carcinoma, suggestive of either
metastasis from sarcomatoid carcinoma of primary
lung origin. In setting of left atrial invasion and thrombo
emboli spread to brain the patient was starts
anticoagulation her neurological status improved and
she was transferred to oncology for chemotherapy.
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Typically, pulmonary SC patients are elderly males with
a chronic history of smoking. Our patient did not have
the usual risk factors of pulmonary SC. She was 45
years of age, 20 years younger than the mean age of
diagnosis and had no history of smoking or alcohol
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occult cancer. Malignancy-associated thrombosis tends
to follow an anatomic pattern of involvement and
includes large artery bifurcations, and small vessel
disease are common stroke mechanisms12,13.In our
patient D-dimer was normal.

abuse. By the time that she presented to the hospital,
the tumor had metastasized to the C3- C5 vertebral
levels. A previous case report has documented SC
metastasis from the lung to the T8 vertebrae of a
63-year-old male who was a chronic smoker that
presented with back pain10. the tumor was causing
severe spinal stenosis. In our case the tumor had not
impinged deeply enough to cause severe spinal
stenosis. However, the cancer itself is quite uncommon
and such a presentation with spinal metastasis with no
symptoms of pain ‘tingling or numbness.

The embolic showering occurs when tumor fragments
are sheared and enter the body's circulation, resulting
in either embolic occlusion or metastatic seeding at
distant sites 16,17. The incidence of lung cancer with
atrial extensions that progress to showering emboli is
unclear.

Embolization to the central nervous system may result
in transient ischemic attack, stroke, or seizure. Strokes
are often recurrent
and embolic and abrupt14.
Cardiogenic emboli account for 15–30% of ischemic
strokes5.

Due to poor prognosis and limited life expectancy. , a
multidisciplinary approach is necessary to address the
physical, emotional, and spiritual needs of the patient
and family regarding end of life and goals of care.
There is no clear evidence that chemotherapy prolongs
survival.

Hypercoagulability in malignancy is common as the
coagulation cascade is activated by tumor cells,
resulting in venous thrombosis in distant sites10,11.

Conclusion:

The ability of malignant cells to interact with the blood
cells of the hemostatic system (endothelial cells,
platelets, and monocytes etc.), induce procoagulants
and inflammatory cytokines contribute to the
pathogenesis of a stroke in these patients14.
D-dimer, a degraded product of fibrin polymer, is a
useful indicator of hypercoagulability, which frequently
increases in cancer-associated stroke. Multiple embolic
strokes with elevated D-dimer alert the possibility of

An atypical presentation and lack of concrete risk
factors in certain patients continues to make
pulmonary sarcomatoid carcinoma a diagnostic
challenge. Although tumor emboli to cerebral are rare
but the possibility should be considered in differential
diagnosis of stroke when dealing with patients who give
off the slightest suspicion of malignancy as earlier
diagnosis will lead to a better patient outcome.
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